Search Results

Showing 1 - 2 of 2 results for "biopharmaceutical"

MLC awards $285m mandate to Janus Henderson

ELIZA BAVIN  |  TUESDAY, 16 JUL 2024  |  NEWS
MLC Asset Management has awarded Janus Henderson a $285 million emerging markets equities mandate. Janus Henderson said the mandate showcased the growing need for Australian institutional investors to have exposure beyond major market indices. The mandate ...

CSL reports new anti-corruption policy, lower emissions

RACHEL ALEMBAKIS  |  FRIDAY, 16 DEC 2011  |  NEWS
Biopharmaceutical company CSL adopted a new anti-bribery and anti-corruption policy, lowered lost time injury frequency rates (LTIFR) by 30% and lowered energy consumption, greenhouse gas and waste intensity per unit of vaccine and plasma production ...
PAGE:
1